Rate My Professor Karoline Freeman

Freeman's career progression at the University of Warwick includes positions as Research Fellow, Senior Research Fellow in Screening and Test Evaluation, and her current role as Associate Professor. Her research specializations encompass methods for test evaluation, evidence synthesis for policy using systematic reviews and routine data, health technology assessment, and health data science, with a focus on breast cancer screening and diagnostic test accuracy. As a member of the Warwick Screening team, she led the analysis of the English Sloane atypia cohort, informing recommendations for managing screen-detected atypia. She serves on the NHS Breast Screening Programme Research, Innovation and Development Advisory Committee. Key publications include 'Challenges in evaluating whole genome sequencing for newborn screening: series of systematic reviews and roadmap for evidence generation for policy advisers' (2025), 'Evidence-informed recommendations on managing breast screening atypia: perspectives of an expert panel' (2024), 'Artificial intelligence to complement rather than replace radiologists in breast screening: systematic review' (2022), 'Test accuracy of faecal calprotectin for inflammatory bowel disease in UK primary care: retrospective cohort study' (2021), 'Faecal calprotectin to detect inflammatory bowel disease: a systematic review and exploratory meta-analysis of test accuracy' (2019), 'Patient safety in ambulance services: a scoping review' (2015), and 'Non-invasive fetal RHD genotyping tests: a systematic review and economic evaluation' (2009). Her contributions have impacted health policy and clinical guidelines in screening programs.